The SURPASS-4 clinical trial was a non-inferiority study comparing tirzepatide to insulin glargine where tirzepartide showed superior A1c and body weight reductions from baseline in adults with T2DM at increased CVD risk.[20] Also, tirzepatide reported a higher occurrence of individuals achieving an A1c below 7% compared to insulin glargine
MAO and COMT are the main enzymes responsible for breaking down dopamine into its byproducts [29]
The prevalence of CHE was reported to be between 30% and 84% in patients with cirrhosis [7,12,13]
Bila perlu, konsultasikan kepada dokter sebelum menggunakan suplemen ini
The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: A systematic review and dose-response meta-analysis
Nevertheless, although off-target inhibition of DPP-9 could be one potential explanation for the association between saxagliptin and heart failure in an experimental setting, it is uncertain whether mean exposure levels of saxagliptin reach a high enough level to affect DPP-9 activity when used at its therapeutic dose in humans